[The effect of aurotherapy on the level of unsaturated fatty acids during the treatment of rheumatoid arthritis patients].
Patients with rheumatic arthritis displayed alterations in blood serum fatty acid spectrum such that polyunsaturated fatty acids tended to be on the decrease, arachidonic acid in particular, monounsaturated ones on the increase. Long-term aurotherapy (for up to 1.5 yr) made for normalization of serum content of unsaturated fatty acids, which observation was accompanied by clinical-and-laboratory remission of rheumatic arthritis. Crisanole effect got higher with incrementing dosage of metallic gold. Results of studies made pathogenetically validate the expediency of long-term aurotherapy in patients with rheumatic arthritis.
Virstiuk
N H
NH
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy*; D004112:Dimercaprol / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004341:Drug Evaluation; D005231:Fatty Acids, Unsaturated / Q000097:blood*; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D050607:Organogold Compounds; D009942:Organometallic Compounds / Q000008:administration & dosage*; D020005:Propanols; D012074:Remission Induction; D013438:Sulfhydryl Compounds; D013997:Time Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D005231:Fatty Acids, Unsaturated; D050607:Organogold Compounds; D009942:Organometallic Compounds; D020005:Propanols; D013438:Sulfhydryl Compounds; D004112:Dimercaprol; C013394:aurotioprol; D007213:Indomethacin
Vplyv auroterapiï na vmist nenasychenykh zhyrnykh kyslot u protsesi likuvannia khvorykh na revmatoïdnyĭ artryt.